3M: Clinical Trials

9 trials sponsored by 3M, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

7 completed, 1 terminated, 1 withdrawn. 9 Phase 3, 1 Phase 2.

By phase and status

PhaseTrialsStatus
Phase 39Completed 7, Terminated 1, Withdrawn 1
Phase 21Completed 1

Follow 3M: new trials by email

Trials (filtered) newest first · largest first

All 9 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Efficacy Study of Patient Preoperative Preps In-vivo
CHG/IPA Surgical skin preparation, Normal saline - Surgical Skin Preparation
Phase 3CompletedSolventum US LLC1542020-07-062024-10-01
Negative Pressure Wound Therapy in Post-Operative Incision Management
dry gauze, The Prevena Incision Management System - Negative-Pressure Wound Therapy
Phase 3CompletedMemorial Sloan Kettering Cancer Center5832016-02-012025-03-18
In Vivo Efficacy Study of Patient Preoperative Preps
3M CHG/IPA Prep C, 3M CHG/IPA Prep CH, ChloraPrep - Bacterial Reduction Post-product Application
Phase 3Completed3M7382014-07-012020-11-23
In-vivo Efficacy Study of Patient Pre-operative Preps
ChloraPrep Hi-Lite Orange, Normal saline, 3M CHG/IPA Prep Tint 10.5-mL - Bacterial Reduction on Skin Flora Post-product Application
Phase 3CompletedSolventum US LLC4262013-10-012024-10-02
In-vivo Efficacy Study of Patient Preoperative Preps
3M CHG/IPA Prep Colorless, 3M CHG/IPA Prep Tint, ChloraPrep - Skin Flora Bacterial Reduction Post-product Application
Phase 3TerminatedSolventum US LLC1712013-10-012024-10-02
Clinical Performance of a Chlorhexidine Antimicrobial Dressing
Chlorhexidine gluconate, Transparent Adhesive Dressing - Catheterization
Phase 2 / Phase 3CompletedSolventum US LLC682007-10-012024-10-24
Imiquimod 5% Cream in Plaque-type Morphea: A Pilot, Prospective Open-label Study
imiquimod 5% cream (Aldara) - Morphea
Phase 3WithdrawnUniversity of Alberta2005-11-012015-04-23
Safety and Efficacy of Imiquimod Applied in Dose-Cycle for Actinic Keratoses
imiquimod - Actinic Keratoses
Phase 3CompletedUniversity of British Columbia202005-02-012006-05-09
Cavilon Breast Trial: Comparison of Cavilon Durable Barrier Cream to Glycerine ("Sorbolene") Cream
Cavilon (TM) Durable Barrier Cream, Sorbolene, Radiotherapy - Breast Cancer
Phase 3CompletedTrans Tasman Radiation Oncology Group3332004-03-012009-05-14

Conditions studied

Breast Neoplasms (1)  ·  Carcinoma, Squamous Cell (1)  ·  Keratosis, Actinic (1)  ·  Precancerous Conditions (1)  ·  Scleroderma, Localized (1)

Interventions

Saline Solution (4)  ·  Sodium Chloride (4)  ·  chlorhexidine gluconate (4)  ·  2-Propanol (3)  ·  Chromogranins (3)  ·  Ethanol (3)  ·  Imiquimod (2)  ·  DAT protocol 1 (1)  ·  Radiotherapy (1)

Countries

United States (5)  ·  Canada (2)  ·  Australia (1)

Top investigators

Muhammad H Bashir, MD, CCRP (2)  ·  Jamie Miller, ADN (1)  ·  Jason K Rivers, M.D. (1)  ·  Mario Leitao, MD (1)  ·  Mark E Rupp, M.D. (1)  ·  Marlene T Dytoc, MD PhD (1)  ·  Peter Graham (1)  ·  Robert R McCormack, BS (1)

Results publications

PMID 23414763, PMID 33416292